Integer’s PT Cut to $90.00

Trending News 🌧️

Integer Holdings Intrinsic Stock Value – Integer Holdings ($NYSE:ITGR) Corporation is a medical device outsource manufacturer based in Plano, Texas. The company’s products include catheters, guidewires, and stents, among others. In a research note, the analysts said that the company’s recent guidance was “disappointing” and that they expect “continued headwinds” in the near term.

Market Price

Integer Holdings Corporation is a medical device company that develops, manufactures, and markets products and services used in a variety of interventional medical procedures. On Thursday, the company’s stock opened at $61.4 and closed at $62.3, up by 0.1% from its last closing price of 62.2. At the time of this writing, most news reports on the company are positive.

VI Analysis – Integer Holdings Intrinsic Stock Value

Integer Holdings Corporation is a medical device outsource manufacturer headquartered in Plano, Texas. The company provides contract manufacturing and design services to original equipment manufacturers in the cardiac and vascular, neuromodulation, orthopedics, pain management, and other therapeutic areas. Integer’s cardiac and vascular business unit offers a full range of services, from design and development through final commercialization, for implantable cardioverter defibrillators , pacemakers, and other devices. The neuromodulation business unit provides design and manufacturing services for implantable spinal cord stimulation devices used to treat chronic pain.

The orthopedics business unit offers a full range of services for orthopedic implants and instrumentation, as well as sports medicine and biologics products. The pain management business unit provides comprehensive design, development, and manufacturing services for a wide range of pain management devices. The company’s shares are currently trading at $62.30, which is 28% below its fair value of $86.70, as calculated by the Valuentum Investment Research team. the market is undervaluing the company’s long-term prospects.

VI Peers

The company designs, develops, manufactures, and markets medical devices and services worldwide. Integer’s competitors in the orthopedics industry include Polynovo Ltd, Globus Medical Inc, and Shenzhen Mindray Bio-Medical Electronics Co Ltd.

– Polynovo Ltd ($ASX:PNV)

Polynovo Ltd is a medical device company that designs, manufactures, and markets biodegradable scaffolds for use in tissue regeneration. The company has a market cap of 1.32B as of 2022 and a Return on Equity of -3.08%. Polynovo’s products are used in a variety of applications, including orthopedics, plastic surgery, and wound care. The company’s products are sold in over 30 countries worldwide.

– Globus Medical Inc ($NYSE:GMED)

Globus Medical Inc is a leading musculoskeletal solutions company. They design, develop, manufacture and market a comprehensive line of products for the orthopedic market. Their products are used in a wide variety of procedures, including spine, hip, and extremities. Globus Medical Inc has a market cap of 7.02B as of 2022, a Return on Equity of 7.24%. Globus Medical is committed to helping improve the quality of life for patients with musculoskeletal disorders. Their products are designed to provide solutions that enable patients to return to their active lifestyles.

– Shenzhen Mindray Bio-Medical Electronics Co Ltd ($SZSE:300760)

Shenzhen Mindray Bio-Medical Electronics Co Ltd is a medical device company that manufactures a range of medical devices and equipment. The company has a market capitalization of $366.53 billion as of 2022 and a return on equity of 23.24%. The company’s products are used in a variety of medical applications, including diagnostics, patient monitoring, and imaging.

Summary

Integer Holdings Corporation is a medical device outsource manufacturer. The company offers a broad range of products and services to the medical device industry, including contract manufacturing, product development, and engineering services. Integer has a long history of helping its customers bring new medical devices and therapies to market.

Today, the company is focused on expanding its reach in the medical device market and continuing to provide high-quality products and services to its customers. Integer is well-positioned to continue to grow and create shareholder value.